Format

Send to

Choose Destination
Sci Transl Med. 2019 Apr 10;11(487). pii: eaat8418. doi: 10.1126/scitranslmed.aat8418.

Impact of antibiotic treatment and host innate immune pressure on enterococcal adaptation in the human bloodstream.

Author information

1
Department of Ophthalmology and Department of Microbiology, Harvard Medical School, Boston, MA 02114, USA.
2
Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, MA 02114, USA.
3
Infectious Disease and Microbiome Program, Broad Institute, Cambridge, MA 02142, USA.
4
Department of Internal Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
5
Program in Molecular Therapeutics, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
6
Department of Ophthalmology and Department of Microbiology, Harvard Medical School, Boston, MA 02114, USA. michael_gilmore@meei.harvard.edu.

Abstract

Multidrug-resistant enterococcal strains emerged in the early 1980s and are now among the leading causes of drug-resistant bacterial infection worldwide. We used functional genomics to study an early bacterial outbreak in patients in a Wisconsin hospital between 1984 and 1988 that was caused by multidrug-resistant Enterococcus faecalis The goal was to determine how a clonal lineage of E. faecalis became adapted to growth and survival in the human bloodstream. Genome sequence analysis revealed a progression of increasingly fixed mutations and repeated independent occurrences of mutations in a relatively small set of genes. Repeated independent mutations suggested selection within the host during the course of infection in response to pressures such as host immunity and antibiotic treatment. We observed repeated independent mutations in a small number of loci, including a little studied polysaccharide utilization pathway and the cydABDC locus. Functional studies showed that mutating these loci rendered E. faecalis better able to withstand antibiotic pressure and innate immune defenses in the human bloodstream. We also observed a shift in mutation pattern that corresponded to the introduction of carbapenem antibiotics in 1987. This work identifies pathways that allow enterococci to survive the transition from the human gut into the bloodstream, enabling them to cause severe bacteremia associated with high mortality.

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center